sefulness and safety in uncovered metallic stent and the covered metallic stent insertion for distal biliary tract obstruction in the unresectable malignancy. -multi-center prospective randomized trial
Not Applicable
- Conditions
- unresectable distal biliary obstruction
- Registration Number
- JPRN-UMIN000015093
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 98
Inclusion Criteria
Not provided
Exclusion Criteria
1.The patient who has bile duct stenosis in the liver from a hepatic portal region. 2.A state is extremely bad from head to foot. 3.) not to include the case that removed duodenal confinement by patient (Stent or the operation that duodenal 3rd portion blocked up. 4. The patient who cannot agree to endoscopic retrograde bile duct pancreatic duct contrasting (ERCP) or endoscopic treatment (endoscopic nipple incision, art of drainage). 5.The patient with the allergy to metal. 6.A patient with a history of the custody of the past metallic stent. 7.A patient considered to be below 30 days in convalescence.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method stent patency obstruction rate
- Secondary Outcome Measures
Name Time Method